Neogenix Oncology, Inc. (Neogenix) announced today that it is entering a research collaboration with IRCCS San Raffaele Pisana in Rome, Italy led by Dr. Fiorella Guadagni. This research agreement reflects the ongoing expansion of Neogenix's collaboration strategy and aims to accelerate the...
Neogenix Oncology, Inc. (Neogenix) announced that researchers at Duke University Medical Center have received approval to move forward with a Phase I trial of the company's lead therapeutic antibody, NPC-1C, in patients with advanced stage pancreatic or colorectal cancer. Duke joins Johns...